Orion Oyj ORNBV

HEL: ORNBV | ISIN: FI0009014377 13/08/2026

79,90 EUR (+2,50%)

(+2,50%) 13/08/2026

Grafiek Orion Oyj

Grafiek Orion Oyj

1 dag1d 2,50%
1 week1w 1,20%
1 maand1m 16,22%
3 maanden3m 15,88%
6 maanden6m 17,24%
1 jaar1j 15,46%
5 jaar5j 129,66%

Orion Oyj in het nieuws

Toon enkel gratis nieuws

10 augustus 2026 · Orion’s license partner Tenax Therapeutics’ Phase 3 LEVEL trial of oral levosimendan in pulmonary hypertension due to heart failure with preserved ejection fraction (PH-HFpEF) did not reach its primary endpoint · Persbericht

17 juli 2026 · Orion Group Half-Year Financial Report January–June 2026 · Persbericht

17 juli 2026 · Orion Corporation’s financial reporting and Annual General Meeting in 2027 · Persbericht

15 juli 2026 · 45,611 Orion Corporation A shares converted into B shares · Persbericht

3 juli 2026 · Orion publishes Half-Year Report for January–June 2026 and holds a webcast on 17 July 2026 · Persbericht

30 juni 2026 · Orion Pharma announces agreement with Shilpa Medicare for nivolumab biosimilar for European market · Persbericht

23 juni 2026 · Orion Pharma’s ODM-212 Granted Orphan Designation for the Treatment of Malignant Mesothelioma by the European Commission · Persbericht

18 juni 2026 · Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) · Persbericht

17 juni 2026 · Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) · Persbericht

16 juni 2026 · Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe